Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

A, Niteroi N Clinical Trials

A listing of A, Niteroi N clinical trials actively recruiting patients volunteers.

RESULTS

Found (973) clinical trials

This is an open-label, randomized (1:1), multicenter, Phase 3 clinical trial evaluating the safety and efficacy of nivolumab in combination with investigational agent sitravatinib compared to docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with ...

Phase

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.

Phase

Research Study of an Investigational Respiratory Syncytial Virus (RSV) Vaccine

Study of an Investigational vaccine against Pneumonia

Phase

The purpose of this study is to compare how much nicotine is in an adult snus user's blood after using two investigational snus products.

Phase N/A

This study is evaluating an oral investigational medication, combined with daily insulin, for adults with type 1 diabetes.

Phase N/A

PMG Research and PMG Research of DuPage Medical Group are looking for men to participate in a research study evaluating the combination of abiraterone (FDA-approved) with olaparib for Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Phase N/A

The purpose of this study is to develop and validate an app called “Write to Hand” that will assess handwriting and motor problems in children. There is 1 study visit that will last one hour. Both parent and child will receive $15.00 for time and effort (IRB # 201809123).

Phase N/A

The purpose of this study is to determine the safety, preliminary evidence of clinical activity, and recommended Phase 2 dose (RP2D) of INCMGA00012 in combination with other agents that may improve the therapeutic efficacy of anti-PD-1 monotherapy.

Phase

The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with metastatic merkel cell carcinoma (MCC).

Phase